| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |